Casdin Capital Revenue and Competitors

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Casdin Capital's estimated annual revenue is currently $11.5M per year.(i)
  • Casdin Capital's estimated revenue per employee is $189,000

Employee Data

  • Casdin Capital has 61 Employees.(i)
  • Casdin Capital grew their employee count by 9% last year.

Casdin Capital's People

NameTitleEmail/Phone
1
Head TalentReveal Email/Phone
2
Director Life Science ResearchReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Director Therapeutics ResearchReveal Email/Phone
6
Director Finance and TaxReveal Email/Phone
7
Director AdministrationReveal Email/Phone
8
Director - Business Development & IRReveal Email/Phone
9
Chief Compliance OfficerReveal Email/Phone
10
Executive Assistant to Chief Investment Officer and FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.8M14-71%N/AN/A
#2
$90M3436%N/AN/A
#3
$5.7M3410%N/AN/A
#4
$449.5M15295%N/AN/A
#5
$26.9M1280%N/AN/A
#6
$7.9M479%N/AN/A
#7
$8.2M494%N/AN/A
#8
$81.6M311-1%N/AN/A
#9
$1.6M130%N/AN/A
#10
$135.2M515-16%N/AN/A
Add Company

What Is Casdin Capital?

Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. At Casdin we start from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. We commit to finding the highest quality management teams doing the work to create high growth companies. We use data to continually advance our knowledge and we are long term investors. We believe in collaboration and transparency and operate at the forefront of innovation.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$11.5M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Casdin Capital News

2022-03-30 - Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

... capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”).

2022-03-22 - Fluidigm Highlights the Strategic Capital Infusion by Casdin ...

Casdin Capital, LLC is a New York-based research investment firm focused on the innovations currently reshaping life sciences and healthcare.

2022-03-22 - Fluidigm Announces Support Agreement with Caligan ...

... Strategic Capital Infusion by Casdin Capital and Viking Global ... Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.4M61-41%$68M
#2
$7.1M61-50%N/A
#3
$12.5M6111%N/A
#4
$12.1M61-5%N/A
#5
$7.1M61-9%N/A